Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Comment by cloinveston Mar 11, 2019 1:09pm
27 Views
Post# 29468635

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Can't wait to see all the basher responses when this goes up

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Can't wait to see all the basher responses when this goes up
JohnRingo wrote:
cloinvest wrote:
OllyOlly wrote: This is not an emerging industry. The big players have already come out of the gate and firmly established themselves, and the smaller and less successful companies are either going bankrupt, delisting, being purchased or simply liquidated. 

Some of the companies FSD is trying to "compete" with have been growing for five years at this point. They have 5-10x the production capacity, they are consistently reducing their overheads to a minimum and are continually expanding, and actively pursuing the other emerging markets like edibles and so on.

FSD says its doing these things, but so far has yet to accomplish so much as one thing -- in fact, from where they said they would be 8 months ago, they have pretty much gone backwards. They've lost their biggest partner and all their funding, and on top of that, started out with 50+ million in cash and are now down to 20 with virtually nothing to show for it. 

"Emerging industry" is a fallacy at this point, and an excuse for people who refuse to cut their losses and accept reality.

The industry has emerged. FSD is not a part of it.

Their desperate attempt to play catch-up two years too late will be met with failure -- but the executives have no other choice at this point, they cannot simply throw up their hands and walk away.

An intelligent investor can though. But, apparently people love to lose money. 

Grocerymoney wrote: Fair.
This is still an emerging industry, we'll have to see in months to come if management can get their act together. Short term, if current levels don't hold FSD is hitting 18-20c

 


Ya ok,right.


good rebuttal cloinvest. Way to instill confidence 



I a figure of speech I was disagreeing with you.
Bullboard Posts